Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed
Agency: Food and Drug Administration
Assistance Listings: 93.103 -- Food and Drug Administration Research
Description
Modified release (MR) oral drug products are considered to have a high risk for alcohol dose dumping (ADD) because they contain large quantities of drug(s), designed to release over a prolonged period of time. Accidental exposure of these products to alcohol can result in the relatively rapid release of large quantities of drug with severe side effects, including death. To mitigate this risk, the FDA recommends conducting an in vitro alcohol dose dumping assessment in 0%, 5%, 20%, and 40% alcoholic dissolution media for all prospective generic versions of MR oral drug products.
To date, ADD assessments have not been harmonized globally. For instance, the U.S. FDA recommends testing up to 40% alcoholic media while the European Medicines Agency recommends testing up to 20% alcoholic media. This type of difference can present a challenge for formulators designing products for multiple markets, as historical data has shown release from MR oral products do not always follow a linear response (either increasing or decreasing) to increasing alcohol concentrations. In addition, interpretation of an ADD assessment may be limited by the inability of the test to predict in vivo behavior.
The purpose of this research is to develop tools that 1) facilitate the development of MR generic drug products that have a low potential for ADD, 2) support regulatory decision making during the assessment of such products, and 3) provide evidence that enables FDA to develop more specific recommendations for efficiently demonstrating a low or comparative potential of alcohol dose dumping for MR oral drug products containing high risk drugs.
Eligibility
Eligible applicants
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
Education
- Public and state institutions of higher education
- Private institutions of higher education
- Independent school districts
Business
- For-profit organizations other than small businesses
- Small businesses
Government
- Federally recognized Native American tribal governments
- State governments
- Special district governments
- County governments
- City or township governments
- Public and Indian housing authorities
Miscellaneous
- Unrestricted
- Other
Additional information
Grantor contact information
Description
terrin.brown@fda.hhs.gov
Documents
No documents are currently available.
Link to additional information
--
Forecasted
Estimated Post Date:
--
Estimated Application Due Date:
--
Estimated Due Date Description:
Not available
Estimated Award Date:
--
Estimated Project Start Date:
--
Fiscal Year:
2024
Award
$--
Program Funding
1
Expected awards
$250,000
Award Minimum
$250,000
Award Maximum
Funding opportunity number:
FOR-FD-24-006
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Consumer protection
Agriculture
Food and nutrition
Category Explanation:
History
Version:
2
Forecast posted date:
November 24, 2023
Archive date:
--